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Breast cancer has been shown to be immunogenic and
can stimulate an antibody immune response. Because of
this immunogenicity, identification of early breast tumor
antigens could allow identification of autoantibodies for
the early detection of breast cancer. In this study, the
TgMMTV-neu genetically engineered mouse model of
breast cancer was used to discover pre-invasive tumor
specific antigens. The mammary tumors that develop in
these mice are genotypically similar to human luminal
breast cancer and the mammary tumor development in
these mice can be evaluated longitudinally, allowing for
collection of sera prior to tumor development and iden-
tification of tumor specific antibodies representing the
earliest alterations in the malignant transformation of
normal mammary epithelium. We identified 6 antigens
that were present in mice prior to the development of
mammary tumors (Pdhx, Otud6b, Stk39, Zpf238, Lgals8,
and Vps35). These proteins were associated with inflam-
mation, autoimmunity, and cellular homeostasis. In
mouse validation cohorts, detecting IgM and IgG anti-
body responses against a panel of three “pre-diagnostic”
tumor antigens discriminated pre-diagnostic sera from
non-transgenic control sera with an AUC of 0.924 (95%
CI 0.81-1.0, p<0.001). We next evaluated samples
obtained from the Women’s Health Initiative Study and
demonstrated women with autoantibodies to the human
homologues of these proteins. The Women’s Health
Initiative study is an observational study following
161,808 healthy postmenopausal women to address issues
of cardiovascular disease, cancer, and osteoporosis.
Samples represented 188 sera, 94 from women who
would eventually develop breast cancer and 94 matched
controls. IgM and IgG autoantibodies to the “pre-diag-
nostic” antigen panel could discriminate the samples of
women who eventually developed breast cancer from
matched controls. The discriminatory potential of the
pre-diagnostic autoantibodies was enhanced if samples
were collected more than 5 months prior to diagnosis
(AUC 0.68; CI 0.565-0.787, p=0.003). These data suggest
that the same pre-invasive breast tumor proteins are
found in mice and women and can predict individuals
who will subsequently develop breast cancer. Future
studies will further validate this panel of early tumor anti-
gens as early breast biomarkers in high risk individuals.
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